Positive Long-term Outcomes with Heartflow FFRCT and Plaque Analysis Demonstrated in ADVANCE-DK Registry at TCT 2024

— Data confirm the use of FFRCT and Plaque Analysis helps assess long-term risks, informing more personalized and effective treatment plans for patients with coronary artery disease

– FFRCT further validated in new study demonstrating diagnostic accuracy and greater ability than CCTA alone to rule out hemodynamically significant stenoses in patients with high-risk NSTE-ACS

Discover how you can use Heartflow to advance your approach to coronary artery disease diagnosis, treatment and management.